NCR1 and acute myeloid leukemia: We observed that the injection of Ncr1+/+ ILC1s prolonged the survival of Ncr1gfp/gfp mice with AML, compared to Ncr1gfp/gfp mice that did not receive Ncr1+/+ ILC1 injections or were injected with Ncr1gfp/gfp ILC1s (Fig. 5k).